FMP
Jacobs Engineering Group Inc.
J
NYSE
Jacobs Engineering Group Inc. provides consulting, technical, scientific, and project delivery services for the government and private sectors in the United States, Europe, Canada, India, rest of Asia, Australia, New Zealand, South America, Mexico, the Middle East, and Africa. The company operates in two segments, Critical Mission Solutions and People & Places Solutions. The Critical Mission Solutions segment provides cybersecurity, data analytics, systems and software application integration and consulting, enterprise and mission IT, engineering and design, nuclear, enterprise level operations and maintenance, and other technical consulting solutions. The People & Places Solutions segment offers data analytics, artificial intelligence and automation, software development, digitally driven consulting, planning and architecture, program management, and other technical consulting solutions. The company is also involved in the management and execution of wind-tunnel design-build projects; and design-build for water and construction management. Jacobs Engineering Group Inc. was founded in 1947 and is headquartered in Dallas, Texas.
121.57 USD
-0.76 (-0.625%)
Danny Green
3 days ago
Jefferies Financial Group Inc. (NYSE:JEF) is a diversified financial services company that operates in investment banking, asset management, and direct investing. It competes with firms like Raymond James Financial, Inc. (RJF), Evercore Inc. (EVR), Stifel Financial Corp. (SF), and Lazard Ltd (LAZ). These companies are key players in the financial services industry, each with unique strengths and market positions. Jefferies Financial Group Inc. has a Return on Invested Capital (ROIC) of 9.52% an...
Tony Dante
3 days ago
SJW Group, listed on the NYSE under the symbol SJW, is a prominent player in the water utility industry. The company provides water services to various communities, ensuring reliable and safe water supply. As a utility company, SJW competes with other water service providers, focusing on operational efficiency and customer satisfaction. On April 28, 2025, SJW is set to release its quarterly earnings, with Wall Street estimating earnings per share (EPS) at $0.35 and revenue at approximately $160...
Gordon Thompson
5 days ago
Raymond James Financial, Inc. (NYSE:RJF) is a diversified financial services company providing a wide range of investment banking, asset management, and financial advisory services. The company operates through several segments, including Capital Markets, Private Client Group, and Asset Management. Raymond James competes with other financial giants like Morgan Stanley and Goldman Sachs in the investment banking sector. Raymond James is set to release its quarterly earnings on April 23, 2025. An...
Parth Sanghvi
7 days ago
Japan’s consumer price index (CPI) data for March showed inflation remaining sticky, with underlying measures well above the Bank of Japan’s target—complicating the central bank’s policy outlook as U.S. tariff negotiations add to economic uncertainty. March CPI Highlights Headline CPI: +3.6% YoY (vs. +3.7% in February; consensus +3.6%) Core CPI (ex‑fresh food): +3.2% YoY (vs. +3.0% in February; consensus +3.2%) Trimmed CPI (ex‑food & energy): +2.9% YoY (vs. +2.6% in February) All ...
Parth Sanghvi
Apr 18, 2025
Japan’s Finance Minister, Katsunobu Kato, told parliament on Friday that Tokyo does not manipulate currency markets to weaken the yen—directly countering U.S. President Donald Trump’s claims that Japan devalues its currency to boost exports. Kato’s remarks come just days before his planned visit to Washington for the G20 finance leaders’ meeting and spring IMF gatherings, where he may hold bilateral talks with U.S. Treasury Secretary Scott Bessent. Japan’s Official Stance No Intentional We...
Stuart Mooney
Apr 17, 2025
Jefferies Financial Group Inc. (NYSE:JEF) is a diversified financial services company that operates in investment banking, asset management, and direct investing. It competes with firms like Raymond James Financial, Evercore, Stifel Financial, and Lazard. These companies are part of the financial services sector, which is known for its focus on capital efficiency and return on investment. Jefferies has a Return on Invested Capital (ROIC) of 23.63% and a Weighted Average Cost of Capital (WACC) o...
Andrew Wynn
Apr 17, 2025
J Sainsbury plc, trading under the symbol PNK:JSAIY, is a prominent player in the UK retail market. Known for its supermarkets, convenience stores, and online services, Sainsbury's competes with other major retailers like Tesco and Asda. The company has a strong presence in the grocery sector and is recognized for its focus on quality and customer service. On April 17, 2025, JSAIY reported its earnings, revealing an earnings per share (EPS) of $0.583, which matched the estimated EPS of $0.583. ...
Andrew Wynn
Apr 17, 2025
J.B. Hunt Transport Services Inc. (NASDAQ:JBHT) is a leading transportation and logistics company in the United States. It provides a range of services, including intermodal, dedicated contract services, and truckload transportation. The company faces competition from other major players like Schneider National and Knight-Swift Transportation. On April 16, 2025, Bascome Majors from Susquehanna set a price target of $140 for JBHT, while the stock was priced at $124.73, indicating a potential upsi...
Gordon Thompson
Apr 15, 2025
Johnson & Johnson (NYSE:JNJ) is a multinational corporation known for its wide range of healthcare products, including pharmaceuticals, medical devices, and consumer health goods. The company competes with other major players in the healthcare industry, such as Pfizer and Merck. On April 15, 2025, JNJ reported impressive financial results, showcasing its strong market position. The company reported earnings per share (EPS) of $2.77, surpassing the estimated $2.58. This result also exceeded the ...
Parth Sanghvi
Apr 15, 2025
Johnson & Johnson (NYSE: JNJ) delivered a solid Q1 performance, surpassing Wall Street expectations for both revenue and profit, as its pharmaceutical arm continues to shine — particularly in oncology. Despite some drag from biosimilar competition and U.S. tariffs, the company lifted its full-year revenue outlook, banking on its growing drug portfolio. Q1 2025 Highlights Revenue: $21.89 billion (+2.4% YoY) Adjusted EPS: $2.77 (vs. $2.59 est.) Innovative Medicines revenue: $13.87 bill...